Biotech Blog Archives: March 2004
next page ·
30 March 2004
The 5% Shuffle - How not to get funded
The 5% Shuffle - How not to get funded
Before you go ahead and pitch your potential to capture some percentage of a market, read this article. Bottom line: market’s aren’t captured, spending budgets are. Focus on capturing your customer’s budgets, not the “market.”
continue reading... » 0 Comments
23 March 2004
A Drug Behemoth In The Making?
A Drug Behemoth In The Making?
“Novartis plus Aventis would create the world’s No. 2 drugmaker, unless politics get in the way “
continue reading... » 0 Comments
22 March 2004
Is genetic engineering next doping threat?
Is genetic engineering next doping threat?
Experts worry that biotechnology could infiltrate sports
continue reading... » 0 Comments
19 March 2004
Boy May Force Change in Norway Bio-Ethics Law
Boy May Force Change in Norway Bio-Ethics Law
“A campaign to save a six-year-old Norwegian boy with a life-threatening blood disorder looked likely Thursday to force Norway to relax strict biotechnology laws in a stinging defeat for the government. “
continue reading... » 0 Comments
18 March 2004
Drug Prices: The Genentech Solution
Drug Prices: The Genentech Solution
“If developed nations want access to breakthrough medicines, they should have to pay full price, says Genentech Chief Executive Arthur D. Levinson. “
continue reading... » 0 Comments
18 March 2004
Amgen Opens The Secret Curtain
Amgen Opens The Secret Curtain
“The biotech leader will host analysts and investors to drum up excitement for its pipeline — and its stock. Will it work? “
